摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 2-[fluoro-4-(trifluoromethylsulfonyloxy)phenyl]propionate | 1377934-40-1

分子结构分类

中文名称
——
中文别名
——
英文名称
methyl 2-[fluoro-4-(trifluoromethylsulfonyloxy)phenyl]propionate
英文别名
methyl 2-[2-fluoro-4-(trifluoromethylsulfonyloxy)phenyl]propanoate;Methyl 2-[fluoro-4-(trifluoromethyl-sulfonyloxy)phenyl]propionate
methyl 2-[fluoro-4-(trifluoromethylsulfonyloxy)phenyl]propionate化学式
CAS
1377934-40-1
化学式
C11H10F4O5S
mdl
——
分子量
330.257
InChiKey
AEELEXWWVHGVCM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    21
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    78
  • 氢给体数:
    0
  • 氢受体数:
    9

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    methyl 2-[fluoro-4-(trifluoromethylsulfonyloxy)phenyl]propionateN-溴代丁二酰亚胺(NBS) 、 (1,2-bis(diphenylphosphino)ethane)palladium(II) chloride 、 偶氮二异丁腈 、 trans-bromo(N-succinimidyl)-bis(triphenylphosphine)palladium(II) 、 sodium carbonate 作用下, 以 四氢呋喃1,4-二氧六环四氯化碳甲苯 为溶剂, 反应 7.0h, 生成
    参考文献:
    名称:
    Synthesis and Biological Evaluation of Derivatives of 2-{2-Fluoro-4-[(2-oxocyclopentyl)methyl]phenyl}propanoic Acid: Nonsteroidal Anti-Inflammatory Drugs with Low Gastric Ulcerogenic Activity
    摘要:
    We previously reported that 2-fluoroloxoprofen has lower gastric ulcerogenic activity than loxoprofen, a nonsteroidal anti-inflammatory drug (NSAID) without selectivity for COX-2. We synthesized derivatives of 2-fluoroloxoprofen and studied their properties. Compared to 2-fluoroloxoprofen, one derivative, 1 la, exhibited higher anti-inflammatory activity and an equivalent ulcerogenic effect. These results suggest that 11a could be therapeutically beneficial for use as an NSAID.
    DOI:
    10.1021/jm300049g
  • 作为产物:
    描述:
    2-(2-fluoro-4-nitrophenyl)propanoic acid盐酸硫酸 、 palladium 10% on activated carbon 、 氢气三乙胺 、 sodium nitrite 作用下, 以 二氯甲烷 为溶剂, 20.0 ℃ 、101.33 kPa 条件下, 反应 32.0h, 生成 methyl 2-[fluoro-4-(trifluoromethylsulfonyloxy)phenyl]propionate
    参考文献:
    名称:
    Synthesis and Biological Evaluation of Derivatives of 2-{2-Fluoro-4-[(2-oxocyclopentyl)methyl]phenyl}propanoic Acid: Nonsteroidal Anti-Inflammatory Drugs with Low Gastric Ulcerogenic Activity
    摘要:
    We previously reported that 2-fluoroloxoprofen has lower gastric ulcerogenic activity than loxoprofen, a nonsteroidal anti-inflammatory drug (NSAID) without selectivity for COX-2. We synthesized derivatives of 2-fluoroloxoprofen and studied their properties. Compared to 2-fluoroloxoprofen, one derivative, 1 la, exhibited higher anti-inflammatory activity and an equivalent ulcerogenic effect. These results suggest that 11a could be therapeutically beneficial for use as an NSAID.
    DOI:
    10.1021/jm300049g
点击查看最新优质反应信息

文献信息

  • 2-FLUOROPHENYL PROPIONIC ACID DERIVATIVES
    申请人:LTT BIO-PHARMA CO., LTD.
    公开号:US20140330026A1
    公开(公告)日:2014-11-06
    Provided are novel 2-fluorophenyl propionic acid derivatives which have excellent anti-inflammatory/analgesic effects while avoiding side effects such as gastrointestinal disorders, namely 2-fluorophenyl propionic acid derivatives represented by the formula (I) below or pharmaceutically acceptable salts thereof, [wherein, R 1 represents a hydrogen atom, a halogen atom, or a substituted or unsubstituted phenyl group, X represents —CH 2 —, —NH—, —O—, or —S—, and Y specifically represents group (II) (wherein, Z 1 represents —CO—, —CH(OH)—, or —CH 2 —, and n represents an integer of 1 or 2.)]
    提供了具有出色抗炎/镇痛效果且避免胃肠道疾病等副作用的新型2-苯丙酸生物,即由下面的式(I)所代表的2-苯丙酸生物或其药学上可接受的盐,其中,R1代表氢原子、卤原子或取代或未取代的苯基,X代表—CH2—、—NH—、—O—或—S—,Y具体表示群(II)(其中,Z1代表—CO—、—CH(OH)—或— —,n代表1或2的整数)。
  • 2-fluorophenyl propionic acid derivatives
    申请人:LTT BIO-PHARMA CO., LTD.
    公开号:US09221786B2
    公开(公告)日:2015-12-29
    Provided are novel 2-fluorophenyl propionic acid derivatives which have excellent anti-inflammatory/analgesic effects while avoiding side effects such as gastrointestinal disorders, namely 2-fluorophenyl propionic acid derivatives represented by the formula (I) below or pharmaceutically acceptable salts thereof, [wherein, R1 represents a hydrogen atom, a halogen atom, or a substituted or unsubstituted phenyl group, X represents —CH2—, —NH—, —O—, or —S—, and Y specifically represents group (II) (wherein, Z1 represents —CO—, —CH(OH)—, or —CH2—, and n represents an integer of 1 or 2.)]
    提供了一种新型的2-苯丙酸生物,具有优异的抗炎/镇痛效果,同时避免了胃肠道疾病等副作用,即由下式(I)所表示的2-苯丙酸生物或其药学上可接受的盐,[其中,R1代表氢原子、卤原子或取代或未取代的苯基,X代表—CH2—、—NH—、—O—或—S—,而Y具体代表群(II)(其中,Z1代表—CO—、—CH(OH)—或— —,n代表1或2的整数)。]
  • 2-FLUOROPHENYLPROPIONIC ACID DERIVATIVE
    申请人:LTT Bio-Pharma Co., Ltd.
    公开号:EP2799424B1
    公开(公告)日:2016-08-17
  • US9221786B2
    申请人:——
    公开号:US9221786B2
    公开(公告)日:2015-12-29
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (反式)-4-壬烯醛 (双(2,2,2-三氯乙基)) (乙腈)二氯镍(II) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (±)17,18-二HETE (±)-辛酰肉碱氯化物 (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (s)-2,3-二羟基丙酸甲酯 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 ([2-(萘-2-基)-4-氧代-4H-色烯-8-基]乙酸) ([1-(甲氧基甲基)-1H-1,2,4-三唑-5-基](苯基)甲酮) (Z)-5-辛烯甲酯 (Z)-4-辛烯醛 (Z)-4-辛烯酸 (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-(+)-5,5'',6,6'',7,7'',8,8''-八氢-3,3''-二叔丁基-1,1''-二-2-萘酚,双钾盐 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-盐酸沙丁胺醇 (S)-溴烯醇内酯 (S)-氨氯地平-d4 (S)-氨基甲酸酯β-D-O-葡糖醛酸 (S)-8-氟苯并二氢吡喃-4-胺 (S)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(((2,2-二氟-1-羟基-7-(甲基磺酰基)-2,3-二氢-1H-茚满-4-基)氧基)-5-氟苄腈 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-2-N-Fmoc-氨基甲基吡咯烷盐酸盐 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯